Valor20202021202220232024TTMFluxo de caixa de investimento1.65 M232 K194 K97 K120 K—Fluxo de caixa de financiamento114.47 M9.87 M74.5 M40.25 M147.34 M—Fluxo de caixa livre106.68 M65.78 M63.27 M48.46 M49.95 M—
Mesoblast Limited - American Depositary Shares
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004.